We are live on ! Find out more
GPP

Great Point Partners Portfolio holdings

AUM $408M
1-Year Est. Return 318.81%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+318.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$408M
AUM Growth
+$99.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$21.4M
2
+$19.8M
3
+$17.7M
4
ANNX icon
Annexon
ANNX
+$14.1M
5
ZBIO
Zenas BioPharma
ZBIO
+$11.8M

Top Sells

1
+$19.9M
2
+$19.7M
3
+$18.5M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$14.4M
5
FULC icon
Fulcrum Therapeutics
FULC
+$9.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTX icon
26
Context Therapeutics
CNTX
$130M
$5.86M 1.44%
2,238,496
-2,445,215
RLMD icon
27
Relmada Therapeutics
RLMD
$684M
$5.86M 1.44%
+842,106
SLN
28
Silence Therapeutics
SLN
$316M
$5.38M 1.32%
1,020,489
+212,457
UNCY icon
29
Unicycive Therapeutics
UNCY
$211M
$5.24M 1.28%
796,558
TENX icon
30
Tenax Therapeutics
TENX
$285M
$5.23M 1.28%
+327,307
PMN icon
31
ProMIS Neurosciences
PMN
$96M
$4.72M 1.16%
+371,402
CGEM icon
32
Cullinan Oncology
CGEM
$798M
$4.26M 1.04%
300,000
-334,032
IMMX icon
33
Immix Biopharma
IMMX
$577M
$3.19M 0.78%
+350,000
RZLT icon
34
Rezolute
RZLT
$372M
$2.9M 0.71%
951,809
PHVS icon
35
Pharvaris
PHVS
$2.25B
$2.34M 0.57%
82,800
HUMA icon
36
Humacyte
HUMA
$240M
$2.28M 0.56%
+3,750,000
AVTX icon
37
Avalo Therapeutics
AVTX
$719M
$1.86M 0.46%
124,666
ALKS icon
38
Alkermes
ALKS
$7.49B
$1.77M 0.43%
+50,000
IRD
39
Opus Genetics
IRD
$323M
$1.48M 0.36%
+324,340
AVXL icon
40
Anavex Life Sciences
AVXL
$232M
– –
0
DNTH icon
41
Dianthus Therapeutics
DNTH
$4.18B
– –
-350,000
FULC icon
42
Fulcrum Therapeutics
FULC
$237M
– –
-800,000
GALT icon
43
Galectin Therapeutics
GALT
$172M
– –
0
IBRX icon
44
ImmunityBio
IBRX
$7.54B
– –
0
IRON icon
45
Disc Medicine
IRON
$2.6B
– –
-250,000
RARE icon
46
Ultragenyx Pharmaceutical
RARE
$2.36B
– –
-300,000
RAPT
47
DELISTED
RAPT Therapeutics
RAPT
– –
-581,187
SANA icon
48
Sana Biotechnology
SANA
$771M
– –
-700,000
SLNO
49
DELISTED
Soleno Therapeutics
SLNO
– –
-400,000
UPB
50
Upstream Bio Inc
UPB
$347M
– –
-300,000
1
2